TARGAN

When Ramin Karimpour founded TARGAN in 2015, his vision was ambitious: use robotics, computer vision, and data analytics to transform poultry production. Turning that vision into a commercial reality required significant capital to demonstrate feasibility and build early prototypes.

That catalyst came through NSF SBIR funding. The early non-dilutive investment enabled TARGAN to de-risk its technology, advance prototype development, and lay the foundation for future growth. To support the company as it secured and managed federal funding, TARGAN partnered with EGC to establish the accounting systems, internal controls, and compliance infrastructure needed to meet agency requirements.

As TARGAN evolved from an R&D startup into a rapidly growing commercial company, EGC scaled its accounting support to match. The company built financial systems that supported increasing operational complexity, investor due diligence, and continued expansion. Along the way, TARGAN attracted over $131 million in private investment, forged partnerships with leading poultry producers, and accelerated commercialization of its technology. 

In 2023, TARGAN was recognized as EGC’s Innovation Award recipient for its contributions to advancing food security, sustainability, and animal welfare through transformative technology. 

In 2026, TARGAN reached a defining milestone with its acquisition by Merck Animal Health. By combining TARGAN’s technology with Merck Animal Health’s global reach and animal health portfolio, the deal is poised to enhance efficiency, animal welfare, and innovation in the poultry industry worldwide. The acquisition underscores how early-stage non-dilutive funding can provide the critical first step in transforming a great vision into a globally impactful company—one improving animal health and food security around the world.